ODDB.org: Open Drug Database

Teva Pharma AG - Cinqaero 100 mg/10 mL, Konzentrat zur Herstellung einer Infusionslösung

Swissmedic Registration	66340	Sequence	01
Product name	Cinqaero 100 mg/10 mL	Description	Konzentrat zur Herstellung einer Infusionslösung
ATC-Classification	R03DX08	ATC-Description	Reslizumab
Introduction of Sequence	09.11.2017

Composition

reslizumabum 100 mg, saccharum, natrii acetas trihydricus, acidum aceticum glaciale, aqua ad iniectabile q.s. ad solutionem pro 10 ml corresp. natrium 1.41 mg.

Packungsbestandteile

Galenic Form

Concentrate for infusion

Excipiens

Active Agent	Dose
Reslizumabum	100mg / 10ml

BAG: Active Agent	Dose
Reslizumabum	100 mg

Inactive agents
Acidum Aceticum Glaciale
Sodium Acetate Trihydrate
Saccharum

Package number	Package Size	EFP	CP	Category	SL	Out of trade (MedRef)
003		567.21	633.30	B	SL	Yes

2025	©ywesee GmbH